140 related articles for article (PubMed ID: 8565165)
1. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.
Raffy O; Azarian R; Brenot F; Parent F; Sitbon O; Petitpretz P; Hervé P; Duroux P; Dinh-Xuan AT; Simonneau G
Circulation; 1996 Feb; 93(3):484-8. PubMed ID: 8565165
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator therapy for primary pulmonary hypertension in children.
Barst RJ; Maislin G; Fishman AP
Circulation; 1999 Mar; 99(9):1197-208. PubMed ID: 10069788
[TBL] [Abstract][Full Text] [Related]
3. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension.
Ting H; Sun XG; Chuang ML; Lewis DA; Hansen JE; Wasserman K
Chest; 2001 Mar; 119(3):824-32. PubMed ID: 11243964
[TBL] [Abstract][Full Text] [Related]
4. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
McLaughlin VV; Genthner DE; Panella MM; Rich S
N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.
Petitpretz P; Brenot F; Azarian R; Parent F; Rain B; Herve P; Simonneau G
Circulation; 1994 Jun; 89(6):2722-7. PubMed ID: 8205687
[TBL] [Abstract][Full Text] [Related]
6. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
Nakayama T; Ishikita T; Matsuura H; Saji T
J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
[TBL] [Abstract][Full Text] [Related]
7. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery.
Schranz D; Zepp F; Iversen S; Wippermann C; Huth R; Zimmer B; Jüngst BK; Oelert H
Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438
[TBL] [Abstract][Full Text] [Related]
8. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
Sitbon O; Brenot F; Denjean A; Bergeron A; Parent F; Azarian R; Herve P; Raffestin B; Simonneau G
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):384-9. PubMed ID: 7842196
[TBL] [Abstract][Full Text] [Related]
10. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
Barst RJ; Rubin LJ; McGoon MD; Caldwell EJ; Long WA; Levy PS
Ann Intern Med; 1994 Sep; 121(6):409-15. PubMed ID: 8053614
[TBL] [Abstract][Full Text] [Related]
11. Acute absolute vasodilatation is associated with a lower vascular wall stiffness in pulmonary arterial hypertension.
Grignola JC; Domingo E; Aguilar R; Vázquez M; López-Messeguer M; Bravo C; Roman A
Int J Cardiol; 2013 Apr; 164(2):227-31. PubMed ID: 21788089
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
Wax D; Garofano R; Barst RJ
Chest; 1999 Oct; 116(4):914-20. PubMed ID: 10531153
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure.
Montalescot G; Drobinski G; Meurin P; Maclouf J; Sotirov I; Philippe F; Choussat R; Morin E; Thomas D
Am J Cardiol; 1998 Sep; 82(6):749-55. PubMed ID: 9761085
[TBL] [Abstract][Full Text] [Related]
14. Continuous therapy with intravenous prostacyclin for primary pulmonary hypertension: a bridge to heart-lung transplantation.
Kramer MR; Fucks S; Simon Z; Berkman N
Isr J Med Sci; 1993 Oct; 29(10):613-6. PubMed ID: 8244657
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension.
Friedman R; Mears JG; Barst RJ
Circulation; 1997 Nov; 96(9):2782-4. PubMed ID: 9386137
[TBL] [Abstract][Full Text] [Related]
16. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.
Nagaya N; Uematsu M; Okano Y; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Miyatake K; Kunieda T
J Am Coll Cardiol; 1999 Oct; 34(4):1188-92. PubMed ID: 10520811
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary and systemic hemodynamic responses to intravenous prostacyclin in broilers.
Wideman RF; Chapman ME; Erf GF
Poult Sci; 2005 Mar; 84(3):442-53. PubMed ID: 15782913
[TBL] [Abstract][Full Text] [Related]
18. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension.
Kumar VH; Swartz DD; Rashid N; Lakshminrusimha S; Ma C; Ryan RM; Morin FC
J Appl Physiol (1985); 2010 Sep; 109(3):677-84. PubMed ID: 20616229
[TBL] [Abstract][Full Text] [Related]
20. Primary pulmonary hypertension.
Gaine SP; Rubin LJ
Lancet; 1998 Aug; 352(9129):719-25. PubMed ID: 9729004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
